Skip to main content
Nicolas Musi, MD, Endocrinology, Los Angeles, CA

Nicolas Musi MD

Endocrinology•Los Angeles, CA

Diabetes, Lipid Metabolism

Professor and Director, Endocrinology Division, Cedars-Sinai Medical Center

Join to view full profile

  • 8723 Alden DrLos Angeles, CA 90048

  • Phone+1 310-423-3870

  • Fax+1 310-423-0429

Dr. Musi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Musi's full profileAlready have an account?

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1995 - 1998
  • Universidad Anahuac School of Medicine
    Universidad Anahuac School of MedicineClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2022 - 2028
  • TX State Medical License
    TX State Medical License 2005 - 2024
  • MA State Medical License
    MA State Medical License 1998 - 2006
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • NFB Regulates Muscle Development and Mitochondrial Function  
    Robert L Reddick, Nicolas Musi, The Journals of Gerontology

Lectures

  • SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet Β-cells 
    San Antonio, TX - 6/16/2014
  • SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet Β-cells 
    San Antonio, TX - 6/16/2014
  • SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet Β-cells 
    San Antonio, TX - 6/16/2014

Press Mentions

  • Are Ozempic and Other Weight Loss Drugs Also Longevity Drugs? Here's What Early Research Suggests
    Are Ozempic and Other Weight Loss Drugs Also Longevity Drugs? Here's What Early Research SuggestsJuly 11th, 2026
  • Slaying 'Zombie Cells' in Blood Vessels Could Be Key to Treating Diabetes, Early Study Finds
    Slaying 'Zombie Cells' in Blood Vessels Could Be Key to Treating Diabetes, Early Study FindsNovember 20th, 2025
  • UConn Center on Aging to Transform Our Understanding of Cellular Senescence in Human Aging with NIH-Funded Tissue Mapping Center Discoveries
    UConn Center on Aging to Transform Our Understanding of Cellular Senescence in Human Aging with NIH-Funded Tissue Mapping Center DiscoveriesDecember 22nd, 2022

Grant Support

  • Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with MetforminCEDARS-SINAI MEDICAL CENTER2024–2029
  • Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with MetforminCEDARS-SINAI MEDICAL CENTER2024–2029
  • Single nuclei RNA-sequencing to map adipose cellular populations and senescent cells in older subjectsCEDARS-SINAI MEDICAL CENTER2022–2027
  • Extracellular Vesicles for Gaining Insights into Tissue Senescent Signatures: A SenNET Pilot and Exploratory ProjectUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2021–2026
  • Extracellular Vesicles for Gaining Insights into Tissue Senescent Signatures: A SenNET Pilot and Exploratory ProjectUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2021–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Nicolas Musi, Dr. Nicolas Musi, MD, Dr. N Musi